2023
DOI: 10.1055/a-2142-4194
|View full text |Cite
|
Sign up to set email alerts
|

The use of a 4.7 mg deslorelin slow release implant in male dogs in the field

Anastasiia Vasetska,
Hanna Körber,
Caroline Pilgram
et al.

Abstract: Objective Slow-release GnRH agonist implants (SRI) are used for reversible medical downregulation of testicular function in male dogs as an alternative to surgery. The 4.7 mg deslorelin SRI should reduce testosterone after 6–8 weeks and induce castration-like effects for 6 months (mon). However, some individual variation is described in the field in regard to onset and duration of effect. For this reason, we aimed to study the effects of the 4.7 mg deslorelin SRI in a larger cohort. Material and meth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2025
2025
2025
2025

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 29 publications
0
0
0
Order By: Relevance